Mesoblast (MESO) EPS (Basic) Growth (1y) (2015 - 2023)
Mesoblast (MESO) EPS (Basic) Growth (1y) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,151.81% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 10.30% |
| Mar 31, 2023 | 23.00% |
| Dec 31, 2022 | 16.96% |
| Sep 30, 2022 | 30.58% |
| Jun 30, 2022 | 9.31% |
| Mar 31, 2022 | 25.24% |
| Dec 31, 2021 | 8.64% |
| Sep 30, 2021 | 17.07% |
| Jun 30, 2021 | 40.88% |
| Mar 31, 2021 | -54.53% |
| Dec 31, 2020 | 4.75% |
| Sep 30, 2020 | -283.64% |
| Jun 30, 2020 | -47.09% |
| Mar 31, 2020 | 43.25% |
| Dec 31, 2019 | 8.06% |
| Sep 30, 2019 | 73.01% |
| Jun 30, 2019 | 6.29% |
| Mar 31, 2019 | -12.02% |
| Dec 31, 2018 | -272.05% |
| Sep 30, 2018 | -157.35% |